Cytotheryx Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
15
- Latest Deal Type
-
Series A
- (In Progress)
- Latest Deal Amount
-
$60M
- Investors
-
6
Cytotheryx General Information
Description
Developer of a therapeutic platform designed to develop cell-based therapies for acute, chronic, and rare liver diseases. The company offers a proprietary bio-incubator that produces scalable, clinically relevant primary human hepatocytes and supports programs in bioartificial liver assist devices, hepatocyte-cell transplant therapy, hepatitis research, gene therapy testing, and preclinical safety and toxicology testing, enabling researchers and healthcare providers to advance effective treatments for liver-related conditions.
Contact Information
Website
www.cytotheryx.comCorporate Office
- 2112 15th Street North West
- Rochester, MN 55901
- United States
Corporate Office
- 2112 15th Street North West
- Rochester, MN 55901
- United States
Cytotheryx Timeline
Cytotheryx Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC (Series A) | 12-Jan-2026 | $60M | In Progress | Generating Revenue | ||
| 6. Seed Round | 01-Mar-2025 | Completed | Generating Revenue | |||
| 5. Seed Round | 30-Aug-2024 | Completed | Generating Revenue | |||
| 4. Seed Round | 31-Mar-2023 | Completed | Generating Revenue | |||
| 3. Seed Round | 01-Aug-2021 | Completed | Startup | |||
| 2. Angel (individual) | 01-Jan-2020 | Completed | Startup | |||
| 1. Joint Venture | 21-Dec-2018 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Cytotheryx Comparisons
Industry
Financing
Details
Cytotheryx Competitors (6)
One of Cytotheryx’s 6 competitors is Satellite Bio, a Venture Capital-Backed company based in Newton, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Satellite Bio | Venture Capital-Backed | Newton, MA | ||||
| Yecuris | Private Equity-Backed | Tualatin, OR | ||||
| Egenesis | Venture Capital-Backed | Cambridge, MA | ||||
| Morphocell Technologies | Venture Capital-Backed | Laval, Canada | ||||
| HepaTx | Venture Capital-Backed | Palo Alto, CA |
Cytotheryx Patents
Cytotheryx Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260354358-A1 | Methods and materials for the conditional hepatic expression of transgenes in mammalian bioincubators | Pending | 07-Oct-2022 | ||
| WO-2024077255-A1 | Methods and materials for the conditional hepatic expression of transgenes in mammalian bioincubators | Inactive | 07-Oct-2022 | ||
| CA-3238170-A1 | Methods of producing and using human hepatocytes and related compositions | Pending | 12-Nov-2021 | ||
| EP-4429457-A1 | Methods of producing and using human hepatocytes and related compositions | Pending | 12-Nov-2021 | ||
| EP-4429457-A4 | Methods of producing and using human hepatocytes and related compositions | Pending | 12-Nov-2021 | A61K35/407 |
Cytotheryx Signals
Cytotheryx Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Children's Minnesota | Corporation | Minority | ||
| FIN Capital Angels | Angel Group | Minority | ||
| Hill Capital Corporation | Growth/Expansion | Minority | ||
| Austin Area Angels | Angel Group | Minority | ||
| Mayo Clinic | Corporation | Minority |
Cytotheryx Acquisitions (1)
Cytotheryx’s most recent deal was a Merger/Acquisition with Ambys Medicines. The deal was made on 23-Feb-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Ambys Medicines | 23-Feb-2023 | Merger/Acquisition | Drug Discovery |
Cytotheryx FAQs
-
When was Cytotheryx founded?
Cytotheryx was founded in 2018.
-
Where is Cytotheryx headquartered?
Cytotheryx is headquartered in Rochester, MN.
-
What is the size of Cytotheryx?
Cytotheryx has 15 total employees.
-
What industry is Cytotheryx in?
Cytotheryx’s primary industry is Biotechnology.
-
Is Cytotheryx a private or public company?
Cytotheryx is a Private company.
-
What is the current valuation of Cytotheryx?
The current valuation of Cytotheryx is .
-
What is Cytotheryx’s current revenue?
The current revenue for Cytotheryx is .
-
How much funding has Cytotheryx raised over time?
Cytotheryx has raised $26.5M.
-
Who are Cytotheryx’s investors?
Children's Minnesota, FIN Capital Angels, Hill Capital Corporation, Austin Area Angels, and Mayo Clinic are 5 of 6 investors who have invested in Cytotheryx.
-
Who are Cytotheryx’s competitors?
Satellite Bio, Yecuris, Egenesis, Morphocell Technologies, and HepaTx are some of the 6 competitors of Cytotheryx.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process